Cuba s Abdala vaccine against Covid-19 shows favorable results
Cuba s Abdala vaccine against Covid-19 shows favorable results
Havana, Jan 26 (Prensa Latina) Cuba s Abdala vaccine candidate demonstrated its safety and immunogenicity against Covid-19, leaders of the study highlighted on Tuesday.
On Twitter, the president of the Business Group of Biotechnological and Pharmaceutical Industries (BioCubaFarma), Eduardo Martinez, detailed that an independent committee for the data analysis of the clinical trial verified those results.
Developed by the Center for Genetic Engineering and Biotechnology (CIGB), Abdala began on December 2nd the first phase of the clinical study with 200 volunteers at the Saturnino Lora Hospital, in the eastern province of Santiago de Cuba.
Abdala vaccine clinical trial is going well in Cuba
Abdala vaccine clinical trial is going well in Cuba
Santiago de Cuba, Jan 9 (Prensa Latina) The clinical trial of the vaccine candidate Abdala, one of the four underway in Cuba, is going well today at the Saturnino Lora Hospital in this eastern city, where it has been taking place for the last month. Dr. Rafael Suárez, director of the healthcare center, reported that the intramuscular application of the preparation for immunization against Covid-19 has hardly presented adverse reactions, mainly associated with discomfort in the area of the puncture.
He indicated that for the second phase, some 600 voluntary participants will be selected, through a call that will be announced with the pertinent requirements.